Armata Pharmaceuticals (ARMP) FCF Margin (2013 - 2020)

Armata Pharmaceuticals has disclosed FCF Margin across 6 years of filings, most recently posting 13319.35% for Q2 2020.

• In Q2 2020, FCF Margin changed N/A year-over-year to 13319.35%; the TTM figure through Jun 2020 stood at 13433.33% (changed N/A YoY), while the FY2017 annual figure was 8043.48%, down 385694.0% from the prior year.
• FCF Margin came in at 13319.35% for Q2 2020 at Armata Pharmaceuticals, down from 11935.0% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 1647.37% in Q3 2017 to a low of 13319.35% in Q2 2020.
• Average FCF Margin over 3 years is 8053.3%, with a median of 10475.0% recorded in 2017.
• Year-over-year, FCF Margin slumped 906928 bps in 2016 and soared 924918 bps in 2017.
• Over 3 years, FCF Margin stood at 6868.18% in 2016, then plunged by 74 bps to 11935.0% in 2017, then fell by 12 bps to 13319.35% in 2020.
• Per Business Quant data, the three most recent FCF Margin figures were 13319.35% in Q2 2020, 11935.0% in Q4 2017, and 1647.37% in Q3 2017.